Charles River Laboratories | CRL - Ordinary Share Capital

Stock Price
169.80
Daily Change
2.06 1.23%
Monthly
2.36%
Yearly
48.09%
Q2 Forecast
166.17

Charles River Laboratories reported $49.22M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agilent USD 282.7M 358K Dec/2025
Align Technology USD 71.75M 736K Dec/2025
Bio-Rad Laboratories USD 26.97M 90K Sep/2025
Bruker USD 151.94M 225K Dec/2025
Cardinal Health USD 238M 1000K Sep/2025
Charles River Laboratories USD 49.22M 2K Dec/2025
Cigna USD 263.46M 3.14M Dec/2025
Concord Medical Services Hldg CNY 130.25M 130.15M Jun/2025
CVS Health USD 1.27B 1000K Dec/2025
Danaher USD 707.7M 800K Mar/2026
Dentsply International USD 199.5M 196.5M Sep/2025
Elevance Health USD 217.37M 4.87M Mar/2026
Galapagos EUR 65.9M 0 Dec/2025
Humana USD 120.59M 318K Dec/2025
Illumina USD 152.8M 900K Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
Intrexon USD 0 0 Jun/2024
IQVIA Holdings USD 169.6M 700K Dec/2025
Laboratory Of America USD 82.2M 700K Dec/2025
Lonza CHF 68.64M 0 Dec/2025
McKesson USD 280M 156M Dec/2025
Merck EUR 434.78M 0 Dec/2025
Mettler Toledo International USD 20.43M 170.6K Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Quest Diagnostics USD 111M 1000K Mar/2026
Revvity USD 113.38M 2.7M Dec/2025
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
United Therapeutics USD 43.64M 740K Dec/2025
UnitedHealth USD 907.68M 1.84M Mar/2026
Veradigm USD 106.07M 103.28M Dec/2022
Waters USD 98.08M 38.55M Dec/2025
West Pharmaceutical Services USD 70.9M 1.1M Mar/2026